Evofem Biosciences gains on media partnership for contraceptive gel

Evofem Biosciences

21/07/2022 15:56

** Shares of Evofem Biosciences  EVFM.O  rise 6% to $0.87
    ** EVFM says it has entered an agreement, under which
content related to its contraceptive gel, Phexxi, will appear in
media company a360 Media's magazines and websites in the U.S.
 urn:newsml:reuters.com:*:nPnbPrnL5a
    ** Short interest in EVFM has climbed sharply after the U.S.
Supreme Court in June struck down the Roe v. Wade ruling that
legalized abortion nationwide, according to S&P Global Market
Intelligence  urn:newsml:reuters.com:*:nL4N2Z131R
    ** The Supreme Court ruling has ignited retail investor
interest in EVFM - Vanda Research  urn:newsml:reuters.com:*:nL4N2YI2N3
    ** As of Wednesday's close, EVFM shares have more than
doubled in value since the Supreme Court ruling

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com))